Rachel Forse
About me
Dr. Rachel Forse, PhD, is a global health researcher and implementation scientist specializing in tuberculosis (TB), health equity, and social protection in low- and middle-income countries. Her work integrates systems thinking, participatory research, and operational leadership to improve care for people affected by poverty-related diseases.
Research
- Social Protection: Co-designing and evaluating psycho-socioeconomic support interventions that reduce the costs of care and improve clinical outcomes.
- Implementation Science: Leading hybrid trials and multi-component complex interventions to improve access, adherence, and quality of care.
- Health Systems Strengthening and Economic Evaluation: Applying costing and evaluation methods to understand the financial and systemic implications of providing healthcare services and support programs.
- Clinical Trial Management: Overseeing the design, implementation, and monitoring of pragmatic and regulatory trials, including randomized controlled trials evaluating new drugs for TB.
Dr. Forse brings over a decade of experience managing large-scale health service delivery programs and supporting the growth of local NGOs across Asia and Africa. She has helped to establish and scale several start-up organizations focused on community-based care and health systems innovation. As Program and Operations Director at and an affiliated researcher at the ̽»¨¾«Ñ¡, she leads research and implementation efforts that bridge science and practice. She is an experienced mixed-methods researcher with expertise in stakeholder-engaged qualitative research, economic evaluation, process evaluation, and implementation science. She currently serves as Principal Investigator or Co-Investigator on multiple studies and projects, including the , the ASPECT trial, and the in Vietnam. Her work aims to improve the lives of people affected by socially determined diseases through evidence-based, community-led interventions.
Networks:
Dr. Forse serves as a Secretariat and Steering Committee member for the Health and Social Protection Action Research and Knowledge Sharing (SPARKS) network, which has members in 22 countries. She is a consultant for the Stop TB Partnership's Global Fund technical support pool.
Articles
- Article: HEALTH AND QUALITY OF LIFE OUTCOMES. 2025;23(1):43
- Article: DIAGNOSTICS. 2025;15(8):1006
- Article: PLOS DIGITAL HEALTH. 2025;4(4):e0000813
- Article: BMJ OPEN. 2024;14(8):e085614
- Article: HEALTH RESEARCH POLICY AND SYSTEMS. 2024;22(1):40
- Article: INFECTIOUS DISEASES OF POVERTY. 2024;13(1):27
- Article: TROPICAL MEDICINE AND INFECTIOUS DISEASE. 2024;9(1):26
- Article: PLOS GLOBAL PUBLIC HEALTH. 2023;3(12):e0002439
- Article: BMC PUBLIC HEALTH. 2023;23(1):2372
- Journal article: JOURNAL OF THORACIC ONCOLOGY. 2023;18(11):s225
- Article: SCIENTIFIC REPORTS. 2023;13(1):15209
- Article: TROPICAL MEDICINE AND INFECTIOUS DISEASE. 2023;8(9):423
- Article: BMJ OPEN. 2023;13(8):e076076
- Article: BMC PUBLIC HEALTH. 2023;23(1):945
- Article: BMJ OPEN. 2023;13(2):e071537
- Article: HUMAN RESOURCES FOR HEALTH. 2022;20(1):25
- Article: PLOS GLOBAL PUBLIC HEALTH. 2022;2(10):e0000257
- Article: SCIENTIFIC REPORTS. 2021;11(1):23895
- Article: BMC HEALTH SERVICES RESEARCH. 2021;21(1):1051
- Article: TROPICAL MEDICINE AND INFECTIOUS DISEASE. 2021;6(3):163
- Article: IMPLEMENTATION SCIENCE. 2021;16(1):54
- Article: PLOS ONE. 2021;16(5):e0250644
- Article: TROPICAL MEDICINE AND INFECTIOUS DISEASE. 2020;5(4):E185-185
- Article: INFECTIOUS DISEASES OF POVERTY. 2020;9(1):166
- Article: TROPICAL MEDICINE AND INFECTIOUS DISEASE. 2020;5(4):E181-181
- Article: TROPICAL MEDICINE AND INFECTIOUS DISEASE. 2020;5(3):E143-143
- Article: BMC PUBLIC HEALTH. 2020;20(1):934
- Article: TROPICAL MEDICINE AND INFECTIOUS DISEASE. 2020;5(1):E26-26
- Article: BMC INFECTIOUS DISEASES. 2020;20(1):134
- Show more
All other publications
- Meeting abstract: ANNALS OF ONCOLOGY. 2024;35:s1620-s1621
- Editorial comment: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2024;28(10):473-475
- Doctoral thesis: 2024
- Editorial comment: BMJ GLOBAL HEALTH. 2020;5(6):e002504